Increased Adsorption Membranes During Cardiopulmonary Bypass
Increased Adsorption Membranes During Cardiopulmonary Bypass. a Randomized Controlled Trial to Evaluate Impact of OXiris® Membrane in Cardiac Surgery Associated Acute Kidney Injury
Sponsor: Baxter Healthcare Corporation
A NA clinical study on Acute Kidney Injury and Cardiac Surgery Associated - Acute Kidney Injury, this trial is completed. The trial is conducted by Baxter Healthcare Corporation and has accumulated 12 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Nov 2024 — Present [monthly]
Completed NA
-
Sep 2024 — Nov 2024 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2021 — Apr 2022 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Apr 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2018 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Hospital Germans TrÃ-es i Pujol de Badalona
- Hospital Universitari de Bellvitge
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .